XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Condensed Statement of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jul. 31, 2023
Jul. 31, 2022
Jul. 31, 2023
Jul. 31, 2022
Income Statement [Abstract]        
Net sales and revenue $ 211,977 $ 240,328 $ 424,691 $ 434,556
Cost of sales (includes $26,399 and $35,319 with related parties for the quarters ended July 31, 2023 and 2022, respectively, and $59,887 and $66,077 with related parties for the six months ended July 31, 2023 and 2022, respectively) 193,625 226,225 396,173 408,545
Gross profit 18,352 14,103 28,518 26,011
Selling, general and administrative expenses (8,618) (6,667) (14,387) (11,866)
Equity in income of unconsolidated affiliates 3,047 3,598 4,537 5,549
Interest and other income, net 3,271 8,181 6,072 8,355
Income before income taxes 16,052 19,215 24,740 28,049
Provision for income taxes (3,768) (4,330) (5,756) (6,178)
Net income 12,284 14,885 18,984 21,871
Net income attributable to noncontrolling interests (3,229) (3,715) (4,693) (5,519)
Net income attributable to REX common shareholders $ 9,055 $ 11,170 $ 14,291 $ 16,352
Weighted average shares outstanding – basic and diluted (in Shares) 17,460 17,772 17,427 17,777
Basic and diluted net income per share attributable to REX common shareholders (in Dollars per share) $ 0.52 $ 0.63 $ 0.82 $ 0.92